Cargando…

How we make cell therapy in Italy

In the 21st century scenario, new therapeutic tools are needed to take up the social and medical challenge posed by the more and more frequent degenerative disorders and by the aging of population. The recent category of advanced therapy medicinal products has been created to comprise cellular, gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montemurro, Tiziana, Viganò, Mariele, Budelli, Silvia, Montelatici, Elisa, Lavazza, Cristiana, Marino, Luigi, Parazzi, Valentina, Lazzari, Lorenza, Giordano, Rosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548721/ https://www.ncbi.nlm.nih.gov/pubmed/26316716 http://dx.doi.org/10.2147/DDDT.S80403

Ejemplares similares

Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product
por: Lavazza, Cristiana, et al.
Publicado: (2022)

Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production
por: Viganò, Mariele, et al.
Publicado: (2018)

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy
por: Canesi, Margherita, et al.
Publicado: (2016)

Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages
por: Capra, Emanuele, et al.
Publicado: (2012)

Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy
por: Giordano, Rosaria, et al.
Publicado: (2021)

Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study
por: Giordano, Rosaria, et al.
Publicado: (2014)

First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome
por: Morello, William, et al.
Publicado: (2022)

What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes
por: Ragni, Enrico, et al.
Publicado: (2013)

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy
por: Calogero, Alessandra Maria, et al.
Publicado: (2018)

Differentiation and migration properties of human foetal umbilical cord perivascular cells: potential for lung repair
por: Montemurro, Tiziana, et al.
Publicado: (2011)

Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function
por: Ulbar, Francesca, et al.
Publicado: (2019)

Chondrogenic and BMP-4 primings confer osteogenesis potential to human cord blood mesenchymal stromal cells delivered with biphasic calcium phosphate ceramics
por: Brennan, Meadhbh Á., et al.
Publicado: (2021)

Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn’s disease patients in a mouse model of colitis
por: Forte, Dorian, et al.
Publicado: (2015)

Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells
por: Manzini, Paolo, et al.
Publicado: (2022)

Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical practice guidelines
por: Hsu, Jonathan, et al.
Publicado: (2011)

A circular RNA map for human induced pluripotent stem cells of foetal origin
por: Barilani, Mario, et al.
Publicado: (2020)

Making SharePoint(® )Chemically Aware™
por: Tallapragada, Kartik, et al.
Publicado: (2012)

The clinical and translational research activities at the INT – IRCCS “Fondazione Pascale” cancer center (Naples, Italy) during the COVID-19 pandemic
por: Buonaguro, Franco M., et al.
Publicado: (2020)

The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies
por: Azzari, C, et al.
Publicado: (2020)

Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction
por: Ciulla, Michele M, et al.
Publicado: (2008)

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation
por: Angelova, Plamena R., et al.
Publicado: (2017)

An RNA editing fingerprint of cancer stem cell reprogramming
por: Crews, Leslie A, et al.
Publicado: (2015)

Why do we treat adolescent idiopathic scoliosis? What we want to obtain and to avoid for our patients. SOSORT 2005 Consensus paper
por: Negrini, Stefano, et al.
Publicado: (2006)

How can we assess the burden of muscle, bone and joint conditions in rural Botswana: context and methods for the MuBoJo focused ethnography
por: Hondras, Maria, et al.
Publicado: (2015)

A method for studying decision-making by guideline development groups
por: Gardner, Benjamin, et al.
Publicado: (2009)

How reliably can we predict the reliability of protein structure predictions?
por: Miklós, István, et al.
Publicado: (2008)

Should we reconsider the routine use of placebo controls in clinical research?
por: Avins, Andrew L, et al.
Publicado: (2012)

“We are not hard to reach, but we may find it hard to trust” …. Involving and engaging ‘seldom listened to’ community voices in clinical translational health research: a social innovation approach
por: Islam, Safina, et al.
Publicado: (2021)

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella, Elena, et al.
Publicado: (2013)

Mass casualty modelling: a spatial tool to support triage decision making
por: Amram, Ofer, et al.
Publicado: (2011)

A time-responsive tool for informing policy making: rapid realist review
por: Saul, Jessie E, et al.
Publicado: (2013)

DMC reports in the 21st century: towards better tools for decision-making
por: Vandemeulebroecke, Marc, et al.
Publicado: (2023)

Closing the Loop: Facilitating the Use of Autopsy Information in Medical Decision Making and Managed Care
por: Nemetz, Peter N.
Publicado: (2008)

We’re only in it for the knowledge? A problem solving turn in environment and health expert elicitation
por: Keune, Hans, et al.
Publicado: (2012)

A framework for production of systematic review based briefings to support evidence-informed decision-making
por: Chambers, Duncan, et al.
Publicado: (2012)

Application of an integrated multi-criteria decision making AHP-TOPSIS methodology for ETL software selection
por: Hanine, Mohamed, et al.
Publicado: (2016)

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform
por: Treweek, Shaun, et al.
Publicado: (2015)

Making use of equity sensitive QALYs: a case study on identifying the worse off across diseases
por: Lindemark, Frode, et al.
Publicado: (2014)

Improving access to shared decision-making for Hispanics/Latinos with inadequately controlled type 2 diabetes mellitus
por: Davidson, Jaime A, et al.
Publicado: (2015)

Rapid-cycle systems modeling to support evidence-informed decision-making during system-wide implementation
por: Sheldrick, R. Christopher, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_03fs0iu4rfj4bm5f5b1g38fjgu